These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 35180376)
1. Increased COVID-19 Severity among Pregnant Patients Infected with SARS-CoV-2 Delta Variant, France. Zayet S; Gendrin V; Gay C; Selles P; Klopfenstein T Emerg Infect Dis; 2022 May; 28(5):1048-1050. PubMed ID: 35180376 [TBL] [Abstract][Full Text] [Related]
2. Coronavirus Disease 2019 (COVID-19) Severity Among Women of Reproductive Age With Symptomatic Laboratory-Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Pregnancy Status-United States, 1 January 2020-25 December 2021. Strid P; Zapata LB; Tong VT; Zambrano LD; Woodworth KR; Riser AP; Galang RR; Gilboa SM; Ellington SR Clin Infect Dis; 2022 Oct; 75(Suppl 2):S317-S325. PubMed ID: 35717652 [TBL] [Abstract][Full Text] [Related]
3. Pregnant women with severe or critical coronavirus disease 2019 have increased composite morbidity compared with nonpregnant matched controls. DeBolt CA; Bianco A; Limaye MA; Silverstein J; Penfield CA; Roman AS; Rosenberg HM; Ferrara L; Lambert C; Khoury R; Bernstein PS; Burd J; Berghella V; Kaplowitz E; Overbey JR; Stone J Am J Obstet Gynecol; 2021 May; 224(5):510.e1-510.e12. PubMed ID: 33221292 [TBL] [Abstract][Full Text] [Related]
4. Counseling in maternal-fetal medicine: SARS-CoV-2 infection in pregnancy. Di Mascio D; Buca D; Berghella V; Khalil A; Rizzo G; Odibo A; Saccone G; Galindo A; Liberati M; D'Antonio F Ultrasound Obstet Gynecol; 2021 May; 57(5):687-697. PubMed ID: 33724545 [TBL] [Abstract][Full Text] [Related]
5. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021. Sánchez Ruiz MA; Adonias G; Robaglia-Schlupp A; Rapilly F; Chabert M; Ramalli L; Reilhes O; Bruel C; Malfait P; Chaud P Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2586-2591. PubMed ID: 35442474 [TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020. Panagiotakopoulos L; Myers TR; Gee J; Lipkind HS; Kharbanda EO; Ryan DS; Williams JTB; Naleway AL; Klein NP; Hambidge SJ; Jacobsen SJ; Glanz JM; Jackson LA; Shimabukuro TT; Weintraub ES MMWR Morb Mortal Wkly Rep; 2020 Sep; 69(38):1355-1359. PubMed ID: 32970660 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers. Khoury R; Bernstein PS; Debolt C; Stone J; Sutton DM; Simpson LL; Limaye MA; Roman AS; Fazzari M; Penfield CA; Ferrara L; Lambert C; Nathan L; Wright R; Bianco A; Wagner B; Goffman D; Gyamfi-Bannerman C; Schweizer WE; Avila K; Khaksari B; Proehl M; Heitor F; Monro J; Keefe DL; D'Alton ME; Brodman M; Makhija SK; Dolan SM Obstet Gynecol; 2020 Aug; 136(2):273-282. PubMed ID: 32555034 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19. Barbero P; Mugüerza L; Herraiz I; García Burguillo A; San Juan R; Forcén L; Mejía I; Batllori E; Montañez MD; Vallejo P; Villar O; García Alcazar D; Galindo A J Matern Fetal Neonatal Med; 2022 Jul; 35(14):2648-2654. PubMed ID: 32689846 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021. Choi YY; Choi SH; Choi JH; Kim DH; Lee JK; Eun BW; Lee H; Kim YK; Ahn B; Song SH; Yun KW J Korean Med Sci; 2022 Oct; 37(42):e303. PubMed ID: 36325607 [TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
15. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19). Savasi VM; Parisi F; Patanè L; Ferrazzi E; Frigerio L; Pellegrino A; Spinillo A; Tateo S; Ottoboni M; Veronese P; Petraglia F; Vergani P; Facchinetti F; Spazzini D; Cetin I Obstet Gynecol; 2020 Aug; 136(2):252-258. PubMed ID: 32433453 [TBL] [Abstract][Full Text] [Related]
16. Intrauterine Fetal Demise in the Third Trimester of Pregnancy Associated With Mild Infection With the SARS-CoV-2 Delta Variant Without Protection From Vaccination. Guan M; Johannesen E; Tang CY; Hsu AL; Barnes CL; Burnam M; McElroy JA; Wan XF J Infect Dis; 2022 Mar; 225(5):748-753. PubMed ID: 35024853 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 in Pregnancy-The First Wave. de Vasconcelos Gaspar A; Santos Silva I Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33807607 [No Abstract] [Full Text] [Related]
19. Clinical Characteristics and Risk of Hypoxemia Development in Women Infected with SARS-CoV-2 during Pregnancy. Sohn Y; Choi HK; Yun J; Kim EH; Kim YK Yonsei Med J; 2024 Jan; 65(1):27-33. PubMed ID: 38154477 [TBL] [Abstract][Full Text] [Related]
20. Clinical Stratification of Pregnant COVID-19 Patients based on Severity: A Single Academic Center Experience. Berry M; Wang A; Clark SM; Harirah HM; Jain S; Olson GL; Pacheco LD; Saade GR; Saad AF Am J Perinatol; 2021 Apr; 38(5):515-522. PubMed ID: 33548937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]